In B2B weakness in the form of undercapitalization is important because companies don't want to make middle term or long term bets on a technology with uncertain prospects for support, maintenance and further development. Signaling "this product might be legacy in 18 months" is worth avoiding.

A rose by any other name still smells sweet, but thornbush isn't the way to market it.